Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/103782
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
| Type: | Journal article |
| Title: | Cabozantinib inhibits abiraterone's upregulation of IGFIR phosphorylation and enhances its anti-prostate cancer activity |
| Author: | Wang, X. Huang, Y. Christie, A. Bowden, M. Lee, G. Kantoff, P. Sweeney, C. |
| Citation: | Clinical Cancer Research, 2015; 21(24):5578-5587 |
| Publisher: | American Association for Cancer Research |
| Issue Date: | 2015 |
| ISSN: | 1078-0432 1557-3265 |
| Statement of Responsibility: | Xiaodong Wang, Ying Huang, Amanda Christie, Michaela Bowden, Gwo-Shu Mary Lee, Philip W. Kantoff and Christopher J. Sweeney |
| Abstract: | Abstract not available |
| Keywords: | Cell Line, Tumor Animals Humans Mice Prostatic Neoplasms Disease Models, Animal Anilides Pyridines Androstenes Receptor Protein-Tyrosine Kinases Receptor, IGF Type 1 Receptors, Androgen Antineoplastic Agents Tumor Burden Xenograft Model Antitumor Assays Signal Transduction Cell Proliferation Phosphorylation Drug Antagonism Drug Resistance, Neoplasm Male |
| Rights: | © 2015 American Association for Cancer Research |
| DOI: | 10.1158/1078-0432.CCR-15-0824 |
| Published version: | http://dx.doi.org/10.1158/1078-0432.ccr-15-0824 |
| Appears in Collections: | Aurora harvest 7 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.